Exhibit 99.1

CureVac N.V., Tübingen, Germany

General Meeting of Shareholders, June 19, 2023

Voting results – Overview

Agenda Item 3	Adoption of the annual accounts over the financial year 2022 - accepted
162.009.808	Number of shares for which valid votes were cast (= 72.37 % of the registered share capital)
161.947.876	Yes votes	99.99 % of the valid votes cast
14.771	No votes	0.0 % of the valid votes cast
Agenda Item 5	Release of managing directors from liability for the exercise of their duties during the financial year 2022 - accepted
162.009.808	Number of shares for which valid votes were cast (= 72.37 % of the registered share capital)
161.888.915	Yes votes	99.94 % of the valid votes cast
85.524	No votes	0.05 % of the valid votes cast
Agenda Item 6	Release of supervisory directors from liability for the exercise of their duties during the financial year 2022 - accepted
162.009.828	Number of shares for which valid votes were cast (= 72.37 % of the registered share capital)
160.595.409	Yes votes	99.19 % of the valid votes cast
1.303.341	No votes	0.80 % of the valid votes cast
Agenda Item 7	Appointment of Michael Brosnan as member of the Supervisory Board - accepted
162.009.808	Number of shares for which valid votes were cast (= 72.37 % of the registered share capital)
155.332.945	Yes votes	95.88 % of the valid votes cast
6.660.769	No votes	4.11 % of the valid votes cast
Agenda Item 8	Appointment of the external auditor for the financial year 2024 - accepted
162.009.808	Number of shares for which valid votes were cast (= 72.37 % of the registered share capital)
161.985.218	Yes votes	99.98 % of the valid votes cast
19.534	No votes	0.01 % of the valid votes cast

1